Benzonatate Dosing for Sinusitis-Related Cough in a 70-Year-Old
For symptomatic relief of cough in a 70-year-old with sinusitis, benzonatate 100-200 mg three times daily as needed is the FDA-approved dose, with a maximum of 600 mg daily in divided doses, but first-generation antihistamine-decongestant combinations are the preferred first-line treatment for sinusitis-related cough rather than benzonatate alone. 1
FDA-Approved Benzonatate Dosing
- Standard dose: 100-200 mg capsule three times daily as needed for cough 1
- Maximum dose: 600 mg daily in three divided doses if necessary to control cough 1
- Duration: Use as needed for symptomatic relief; no specific maximum duration is specified in FDA labeling 1
- Critical safety instruction: Capsules must be swallowed whole—never broken, chewed, dissolved, cut, or crushed due to risk of local anesthetic effects and potential toxicity 1
Important Context: Benzonatate Is Not First-Line for Sinusitis Cough
The American College of Chest Physicians recommends first-generation antihistamine-decongestant (A/D) combinations as the primary treatment for cough related to upper airway cough syndrome (UACS) from sinusitis, not benzonatate. 2, 3, 4
Preferred Treatment Approach for This Patient
First-line: First-generation antihistamine-decongestant combination twice daily 2, 3
Adjunctive therapies to combine with A/D:
Benzonatate role: Consider as adjunctive symptomatic relief for persistent cough while treating the underlying sinusitis 1, 6
Special Considerations for a 70-Year-Old Patient
Age-Related Precautions with Decongestants
- Screen for contraindications before prescribing decongestants: hypertension, glaucoma, benign prostatic hypertrophy with urinary symptoms, anxiety, or cardiac arrhythmias 2
- If decongestants are contraindicated, intranasal ipratropium can be substituted 2
- Start A/D therapy once daily at bedtime for several days before advancing to twice daily to minimize sedation 2
Benzonatate Safety in Elderly
- Benzonatate has been studied in advanced cancer patients and shows a favorable safety profile at recommended doses 6
- Critical warning: Overdose can cause rapid cardiac arrest and death, even in adults—emphasize proper dosing and storage away from others 7
- The capsule must never be chewed or opened, as local anesthetic effects can cause severe toxicity 1, 7
Duration of Treatment
For acute sinusitis with cough:
- Continue benzonatate as needed for symptomatic cough relief 1
- Continue A/D therapy until cough resolves, typically requiring several weeks to months 2
- If symptoms persist beyond 10-14 days without improvement, consider bacterial sinusitis and evaluate for antibiotics 2, 3
For chronic sinusitis (symptoms >12 weeks):
- Longer treatment courses may be needed, with intranasal corticosteroids continued for at least 3 months after cough resolution 2
- Consider specialist referral if refractory to medical management 2, 4
Common Pitfalls to Avoid
- Do not use benzonatate as monotherapy for sinusitis-related cough—it only suppresses the cough reflex without treating the underlying postnasal drip 1
- Avoid topical nasal decongestants (oxymetazoline) for more than 3-5 days to prevent rebound congestion (rhinitis medicamentosa) 2, 3
- Do not prescribe antibiotics for viral rhinosinusitis—reserve for confirmed bacterial sinusitis with persistent (>10 days), severe, or worsening symptoms 2, 3
- Ensure the patient understands benzonatate capsules must be swallowed whole to avoid life-threatening local anesthetic toxicity 1, 7
When Cough Persists Despite Treatment
If cough continues after appropriate sinusitis treatment:
- Evaluate for asthma with bronchoprovocation testing, as asthma frequently coexists with sinusitis 2, 3
- Consider gastroesophageal reflux disease (GERD) as a contributing factor 2
- Assess for eosinophilic bronchitis with sputum eosinophil count or exhaled nitric oxide 2
- If all testing is negative and cough remains unexplained, consider speech pathology therapy or gabapentin trial 2